Dermasim®

Clotrimazole

Prescribing Details



Description

Dermasim® is the preparation of Clotrimazole which is a broad-spectrum antifungal. It also exhibits activity against Trichomonas, Staphylococci, Streptococci and Bacteroides.


Uses

No Data


Indications

Dermasim® is indicated mould and for all other fungi dermatomycoses and skin due diseases to showing dermatophytes superinfections (e.g., with Trichophyton these fungi. species), yeasts (e.g., Candida species), mould and other fungi and skin diseases showing superinfections with these fungi.

The above mentioned dermatomycoses include interdigital mycoses (e.g., athlete's foot), paronychias (associated with nail mycoses), mycoses in skin and skin folds, candida vulvitis, candida balanitis, pityriasis versicolor, ringworn and erythrasma.


Dosage and administration

Route of administration: Dermasim® 1 % Cream should be applied topically.
Wash skin with soap and water and dry thoroughly. Apply a thin layer of the cream 2-3 times daily and gently message
over Best results affected in area athlete's as directed foot and by the ringworm physician. are For usually athlete's obtained foot, with pay 4 special weeks use attention of this to the product spaces and in between jock itch the with toes. 2
weeks disappearance use. The of all cream signs of should be inrection. applied If two satisfactory or three results times have daily not for occurred one month within or these for at times, least consult two a weeks physician. after the For best results, follow the directions and continue treatment for length of time indicated.
Candida Dermatomycoses: vulvitis and 3-4 candida weeks. balanitis: 1-2 weeks.
Erythrasma and pityriasis versicolor: (approx.) 3 weeks.
In fungal disappearance infection of all of signs the of feet, disease. to prevent relapses, treatment should be continued for about 2 weeks beyond the


Use in pregnancy & lactation

Pregnancy: Clotrimazole can be used during pregnancy but only under the supervision of a physician.

Lactation: As many drugs are excreted in human milk, a decision must be made whether to discontinue breastfeeding or to discontinue clotrimazole therapy.


Geriatric use
No Data

Precautions

For external use only. Not intended for ophthalmic use. Discontinue the product if skin rash or new irritation occurs.


Side effects

Local reactions including skin irritation and burning may occur. Contact allergic dermatitis has also been reported.


Contraindications

Possible hypersensitivity to clotrimazole or any other ingredients or the product.


Drug interactions

When used together, this cream may cause damage to latex contraceptives. Consequently the effectiveness of such contraceptives may be reduced. Patients should be advised to use alternative precautions for at least five days after using this cream.


Overdose

No risk of acute intoxication is seen as it is unlikely to occur following a single dermal application of an overdose or inadvertent oral ingestion. There is no specific antidote.


Preparation

No Data


Pharmaceutical precautions

Store in a cool (below 25°C) and dry place protected from light. Keep away from the reach of children.


Presentation

Dermasim® 1% Cream: Each gram contains Clotrimazole BP 10 mg.


Package quantitie

Denmasim® 1% Cream: Tube or 15 g.